Wu Yiyang, Song Zimu, Sun Kuisheng, Rong Shikuo, Gao Peng, Wang Feng, Sun Tao
Department of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China.
Ningxia Key Laboratory of Cerebrocranial Diseases, Incubation Base of National Key Laboratory, Ningxia Medical University, Yinchuan, People's Republic of China.
Onco Targets Ther. 2019 Dec 24;12:11413-11423. doi: 10.2147/OTT.S236598. eCollection 2019.
To explore the value of F-NLR-AGR score based on preoperative fibrinogen, neutrophil to lymphocyte ratio (NLR), and albumin to globulin ratio (AGR) in predicting the prognosis in patients with glioma.
203 glioma patients were retrospectively analyzed. Receiver-operating characteristic (ROC) curve analysis was used to determine the optimal cut-off values for NLR, AGR, and fibrinogen. According to these cut-off values, patients with high NLR (>1.90), low AGR (<1.54), and elevated fibrinogen (>2.61 g/L) were defined as a score of 3, if none of the patients' three parameters met these standards they were given a score of 0, if any two or one parameter met these standards they were scored as 2 or 1, respectively. The correlation between F-NLR-AGR score and glioma grade was also evaluated.
The three-year overall survival (OS) rate and the mean overall survival in patients with F-NLR-AGR=3 were lower than those of patients with F-NLR-AGR = 2, 1 or 0 [17.6% vs 35.2%, 66.9% or 83.7% (26.0 vs 39.0, 64.0 or 81.0 months), P<0.001]. Multivariate analysis revealed that age (HR=2.071; 95% CI=1.195-3.588; P=0.009), WHO grade (P<0.001), and F-NLR-AGR score (P<0.001) were independent prognostic factors for OS. Spearman's rank correlation analysis revealed that F-NLR-AGR score was positively correlated with glioma grade (r=0.278, P<0.01).
Preoperative F-NLR-AGR score was correlated with glioma grading, high F-NLR-AGR score was an independent predictor of poor prognosis in glioma. Therefore, the scoring system may be applied in clinical practice to identify high-risk patients.
探讨基于术前纤维蛋白原、中性粒细胞与淋巴细胞比值(NLR)及白蛋白与球蛋白比值(AGR)的F-NLR-AGR评分在预测胶质瘤患者预后中的价值。
回顾性分析203例胶质瘤患者。采用受试者工作特征(ROC)曲线分析确定NLR、AGR和纤维蛋白原的最佳截断值。根据这些截断值,NLR高(>1.90)、AGR低(<1.54)且纤维蛋白原升高(>2.61 g/L)的患者评分为3分;若患者的三个参数均未达到这些标准,则评分为0分;若有两个或一个参数达到这些标准,则分别评分为2分或1分。同时评估F-NLR-AGR评分与胶质瘤分级之间的相关性。
F-NLR-AGR = 3的患者三年总生存率(OS)和平均总生存期低于F-NLR-AGR = 2、1或0的患者[17.6%对35.2%、66.9%或83.7%(26.0对39.0、64.0或81.0个月),P<0.001]。多因素分析显示年龄(HR = 2.071;95% CI = 1.195 - 3.588;P = 0.009)、世界卫生组织(WHO)分级(P<0.001)和F-NLR-AGR评分(P<0.001)是OS的独立预后因素。Spearman等级相关分析显示F-NLR-AGR评分与胶质瘤分级呈正相关(r = 0.278,P<0.01)。
术前F-NLR-AGR评分与胶质瘤分级相关,高F-NLR-AGR评分是胶质瘤预后不良的独立预测因素。因此,该评分系统可应用于临床实践以识别高危患者。